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ditoriallveolar  and  cystic  echinococcosis  in  Europe:  Old  burdens  and  new
hallengesThe European Scientiﬁc Counsel for Companion Animal Para-
ites (ESCCAP) hosted the major European “ECHINOCOCCUS14”
cientiﬁc conference at the Lithuanian Academy of Sciences in Vil-
ius, Lithuania from 8th to 9th October, 2014. This special issue of
eterinary Parasitology, volume xx, 2015 contains papers from the
nvited keynote speakers.
Needless to say, there are substantial biological, epidemiologi-
al and clinical data gaps in our knowledge about zoonoses, which
ave not received enough attention over decades in either the
cientiﬁc world or the public health and clinical services arenas.
evertheless, convincing evidence of emergence, especially for
lveolar echinococcosis (AE), is accumulating in the old central
uropean endemic area as well as in the eastern Baltic region
Vuitton et al., 2015; Gottstein et al., 2015a, Marcinkute˙ et al.,
015). The ECHINOCOCCUS14 conference provided an excellent
one health” platform to update current understanding, both in
asic research and in the clinical, epidemiological and veterinary
ublic health ﬁelds, to identify knowledge gaps in Europe and, most
mportantly, to critically assess conclusions that can be drawn from
xisting scientiﬁc information and data sets.
. Taxonomic revisions in process and new molecular
pidemiology approaches
The taxonomy within the genus Echinococcus is still under
evision and remains controversial (Romig et al., 2015; Lymbery
t al., 2015). The causative agents of cystic echinococcosis (CE),
 paraphyletic group of phenotypes with high genetic variation,
re now recognized as a complex (Echinococcus granulosus sensu
ato) of species, strains and genotypes. For Europe, E. granulosus
ensu stricto (sheep strain, genotypes G1-3) represents the prin-
ipal causative agent of CE, affecting humans mainly in southern
nd southeastern Europe. The pig strain (G7) is the main human
E agent in the Baltic countries (Marcinkute˙  et al., 2015). For
his genotype, it was recently proposed to resurrect the historic
ame, Echinococcus intermedius, based on biogeographic, genetic
nd morphological evidence (Lymbery et al., 2015). Furthermore,
wo genotypes of Echinococcus canadensis (G8 and G10) have been
ocumented in northern Europe and the fascinating biology of this
ess pathogenic species was recently investigated in appropriate
etail in Finland (Oksanen and Lavikainen, 2015). A correct and
ell-accepted delineation of Echinococcus taxonomy is urgently
eeded for use in the veterinary and public health ﬁelds.
ttp://dx.doi.org/10.1016/j.vetpar.2015.08.001
304-4017/© 2015 Published by Elsevier B.V.Recently developed molecular epidemiological tools allow, for
the ﬁrst time, genotyping studies to trace the dynamic activity of
the parasite. The need to type isolates of both E. granulosus s.l. and
Echinococcus multilocularis in animals and humans is fundamental
for better understanding emergence of potentially more virulent
and zoonotic isolates (Alvarez Rojas et al., 2014; Knapp et al., 2015).
2. Exciting insights in genomics and parasite-host
interactions
Genomic and transcriptomic analyses published in 2013, for
both E. multilocularis and E. granulosus,  provide new information
to systematically approach targeted drug design and development,
and may  also facilitate the development of new vaccine candi-
dates and diagnostic antigens that reﬂect clinically relevant disease
stages of AE and CE (Koziol and Brehm, 2015). Finally, the realisa-
tion that a large proportion of E. multilocularis-infected individuals
remain asymptomatic and healthy, may  provide leads for the elu-
cidation of immune protective mechanisms and pathways and,
thereby, contribute to the development of new immunotherapeutic
agents.
Studies on host-parasite interactions and host immunity of AE
provided exciting new insights into a range of infection and dis-
ease pathways in human and rodent intermediate hosts (Gottstein
et al., 2015b). In humans, there is now general agreement that, in a
substantial proportion of infected individuals, parasite and disease
development is aborted. However, in a, fortunately, much smaller
proportion of individuals, the parasite is successful in directing the
host immune response towards anergy; the down-regulation of
Th1-dependent inﬂammatory processes creates the periparasitic
conditions that allow slow parasite development and proliferation.
In AIDS or other immunocompromised conditions such medical
post-organ transplant immunosuppression, the parasite prolifer-
ates unrestrictedly, often with fatal outcomes. Identiﬁcation of
key molecules, such as parasite metabolites, that drive the host
immune system towards anergy or, conversely, towards an effec-
tive immune response against the parasite metacestode, remains a
challenge. Advances in this ﬁeld could uncover the pathways lead-
ing to the remission of lesions and cure, and to the identiﬁcation of
immunotherapeutic agents.
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. Persistent or emerging epidemiological situation of
lveolar and cystic echinococcosis in Europe
Over the past decades, multiple studies have addressed the
istribution of E. multilocularis in carnivores in Europe result-
ng in better-deﬁned boundaries of the areas where this parasite
s endemic. An expansion has been observed in northern, east-
rn and western Europe (Gottstein et al., 2015a). This has been
specially noted in the Baltic region, where not only high preva-
ences in foxes and raccoon dogs have been documented but
lso more human AE cases have been registered in Lithuania and
eighbouring Poland (Marcinkute˙ et al., 2015). Furthermore, the
mergence of E. multilocularis in fox populations has been con-
rmed in the urban areas of the well-known endemic regions and in
any surrounding European countries, including the Netherlands,
elgium, Estonia, Slovakia, Romania and Slovenia. Due to long
ncubation periods, new cases of AE can be expected, with some
elay, in these areas (Gottstein et al., 2015a). On the other hand,
he epidemiological situation on the southern border seems to be
table, at least in Italy and Switzerland (Conraths and Deplazes,
015). More recently, E. multilocularis has been documented in
oxes in Denmark and Sweden but not, to date, in Norway or
inland (Wahlström et al., 2015). The interpretation of these ﬁnd-
ngs is controversial; the extent to which the wider geographical
istribution and higher numbers of cases is real, caused by natural
r anthropogenic migration of infected animals, or simply due to
ore intensive investigations and improved methods of detection,
emains unclear.
Across Europe, as elsewhere, the actual prevalence of CE remains
argely unknown, partly due to the lack of efﬁcient and dedicated
eporting systems. In this regard, a European register was  initiated
ithin the FP7HERACLES project aiming to provide prospective
ata on the epidemiology and clinical features of human CE. For
E, a European register – “EurEchinoReg” – was  initiated at the
nd of the 20th century within the framework of the European
GXXIV/SANCO programme. This register represents a cornerstone
or further epidemiological studies across Europe (Vuitton et al.,
015). France, so far, is the only European country that has elab-
rated and maintained a long-term and standardised AE-registry
ystem, presently run by the Centre Collaborateur OMS/WHO Col-
aborating Centre of the Université de Franche-Comté in Besanc¸ on,
rance.
ransmission of Echinococcus multilocularis in Europe: gaps
n our knowledge
Transmission of E. multilocularis is determined by ecological
actors of the hosts such as behaviour (predator-prey relation-
hip, defecating behaviour, activity patterns of deﬁnitive hosts and
odent dietary preferences), and is strongly dependent on host
opulation dynamics in various habitats; these complex ecologi-
al features have comprehensively been reviewed by Raoul et al.
2015). However, key intermediate hosts have been identiﬁed for
nly some regions of Central Europe, illustrating fundamental gaps
n the epidemiological knowledge for most of the other endemic
reas. Therefore, it is not possible to understand or even predict
uture parasite dynamics in new localities, for example, the recently
iscovered low endemic area of Sweden.
. Alveolar and cystic echinococcosis control strategies:
urope could do more!The zoonotic diseases, AE and CE, have recently been placed
n the Neglected Tropical Disease (NTD) list of the World Health
rganisation (WHO)/Tropical Disease Research (TDR). Both dis-logy 213 (2015) 73–75
eases rarely cause death but rather prolonged, and during the end
stage of the disease, severe suffering (Stojkovic et al., 2014). They
are not easy diseases to prevent, diagnose or treat. In particular, the
wildlife cycle of E. multilocularis resists control on a large scale but,
in highly populated areas with high infection pressure, interven-
tion strategies are feasible and facilitate reduced risk of infection
(Hegglin and Deplazes, 2013). Intervention strategies to minimise
the infection risk of AE to humans must consider the complex
ecology of the wild hosts, the possible involvement of domestic
dogs (Deplazes et al., 2011) and foresee effects of planned human-
wildlife interactions such as increased hunting of foxes, the main
deﬁnitive hosts (Hegglin et al., 2015).
Worldwide studies have been conducted investigating risk fac-
tors for E. granulosus infection and indicate that sociocultural and
economic factors have to be considered. Epidemiological factors
associated with increased risk of E. granulosus infection in dogs
have been reviewed recently (Otero-Abad and Torgerson, 2013).
Feeding of dogs with raw viscera, inadequate systems for elim-
ination of by-products, home slaughtering of livestock without
meat inspection, free access of dogs to raw carcasses and offal of
fallen livestock or wild animals, lack of deworming of dogs and
owners’ poor health education have been identiﬁed as major risk
factors.
Echinococcus granulosus circulating in domesticated animals is,
in principle, more amenable to control measures but traditional
habits of slaughtering and lack of economic means and long-term
commitment remain the major obstacles to eradication in many
regions of Europe and more so in poorer parts of the world (Craig
and Larrieu, 2006). In Europe, control programmes for CE date
back to the second half of the 19th century and have been imple-
mented over the years in several countries, with success in some
insular situations (Iceland and Cyprus) but only partial or no suc-
cess in other regions (e.g. the Autonomous Community of La Rioja
in Spain, the island of Sardinia in Italy and the nation of Wales
in the United Kingdom). Therefore, in addition to the classical
control tools, including targeting dogs and sheep with veterinary
interventions and public education campaigns, the immunisation
of sheep with the EG95 vaccine is a promising, innovative tool
that could contribute signiﬁcantly to the control of the disease in
animals (Lightowlers, 2013). The WHO, through its Informal Work-
ing Group on echinococcosis (WHO-IWGE), has recommended
pilot testing of sheep immunisation in ﬁeld trials, with the inten-
tion to fully evaluating its effectiveness, cost, feasibility and
sustainability.
In the last two  decades, parasitological, immunological (e.g.
coproantigen detection) and DNA based methods have been
improved or newly developed to detect E. multilocularis (Conraths
and Deplazes, 2015) and E. granulosus s.l. (Craig et al., 2015) in ani-
mals and in environmental samples. The methods can be selected
for individual diagnosis in animals or for a wide range of epi-
demiological or control purposes. Most of the tests have been well
validated and can be adapted to suit a variety of epidemiological
needs, sample size and ﬁnancial resources, alone or in combina-
tion. However, what is lacking is a generally accepted gold standard
though, recently, a laborious and high-cost PCR-based method
was documented to have a higher sensitivity compared with the
standard sedimentation and counting technique (Isaksson et al.,
2014). Further quality improvement and standardisation of tests
is needed, particularly for long-term monitoring during the con-
solidation phase of control programs, and for the generation of
biogeographic and disease-related data.
In conclusion, with only a few exceptions, sufﬁcient epidemio-
logical baseline data are available for the implementation of control
strategies in selected endemic settings of AE and CE and, especially,
for Europe. There are no reasons not to establish control programs
in the near future!
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. The diagnostic and clinical challenge of alveolar and
ystic echinococcosis in humans
What we know and offer to patients is largely based on the work
nd experience of a few clinical groups worldwide (Stojkovic et al.,
014). With very scarce funding resources, it has been possible to
onduct only a few formal clinical trials so far. The data collected
re predominately from case studies and individual patient reports.
ata pooling is difﬁcult, if not impossible, since data collection has
ot been standardised. Published studies are highly heterogeneous
egarding inclusion criteria and important clinical endpoints. Addi-
ionally, most studies do not report on sufﬁciently long follow-up
eriods to reliably exclude relapse, a major problem in patients
ith AE and CE.
The WHO-IWGE has, on two occasions – 1996 and 2010 – assem-
led the available evidence on AE and CE diagnosis and treatment
n humans and gathered it into a clinical guideline (Brunetti et al.,
010).
For CE, a key element of these guidelines is the ultrasound-
ased WHO  CE cyst classiﬁcation and its predecessors (Gharbi
t al., 1981; Pawlowski et al., 2001; WHO-IWGE, 2003). On this
asis, stage-speciﬁc treatment algorithms are crystallising. They
re, however, far from being fully evaluated and, more importantly,
re only reluctantly taken up by health services (Brunetti et al.,
011).
Similarly, in AE, substantial progress has been made in diagno-
is, staging and treatment (Stojkovic et al., 2014). This includes new
igh-tech approaches to avoid or at least postpone liver transplan-
ation in advanced disease with biliary tree stenosis by endoscopic
ilatation and stenting.
There are two major setting-speciﬁc reasons why progress in
he clinical management of AE and CE is not being made at a satis-
actory rate. Firstly, in poorer countries there are many patients
ut the means to diagnose and stage AE and CE, such as ultra-
ound machines, are lacking. For the same reason, treatment that,
n advanced cases, requires substantial expertise and training in
urgery, percutaneous techniques and anaesthesia is suboptimal
r not available for patients in need. Cooperation and support is in
emand. Secondly, although in richer countries all this is available,
atients – mostly immigrants with CE – are few and dispersed. In
hese cases, referral of patients to multidisciplinary treatment cen-
res enhances experience and quality of care (Stojkovic et al., 2014;
runetti et al., 2011).
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